Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07017517Not ApplicableRecruiting

NLRP3 Inflammasome and Physical Therapy in ICU-Acquired Weakness

Role: collaborator

NCT07032870Recruiting

Physical Therapist Inter-Rater Reliability in Neuro-Muscle Ultrasound in Critically Ill Patients

Role: collaborator

NCT06758024Not ApplicableRecruiting

PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

Role: collaborator

NCT04979897Completed

Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic

Role: collaborator

All 4 trials loaded